Reversal of the effect of delipidation was accomplished by the addition ofphysiologic concentrations of high density lipoprotein (HDL). In contrast, as much as two times normal serum concentration of low density or very low density lipoprotein were ineffective. The ability of normal plasma (or serum) to inhibit the pyrogenic activity of LPS, lost after delipidation, was also restored after the addition of HDL. Preliminary results suggested that prior modifications of the LPS, probably disaggregation, may be required before interaction with HDL.
INTRODUCTION
Gram-negative bacterial septicemia in man may be complicated by hypotensive shock and disseminated intravascular coagulation. The major evidence to support a role for endotoxin or bacterial lipopolysaccharide (LPS)l in the induction of these pathophysiological changes is twofold. It has been shown that injection of purified LPS into experimental animals produces most, if not all, of the pathophysiologic This is publication 1818 from Scripps Clinic and Research Foundation.
Received for publication 25 May 1979 and in revised form 23 July 1979. 1516 changes observed in gram-negative septicemia. Most recently, the studies of McCabe and his collaborators (1, 2) and Braude et al. (3) provided additional evidence to support a role for LPS. They showed that antiserum to the core glycolipid of LPS is protective in experimental sepsis induced with heterologous bacteria.
It is clear that LPS must first interact with both the formed, as well as the soluble elements of blood. The main focus in previous studies of intravascular reac- tions of LPS has been on the distribution of LPS among the formed elements of blood, although it was established over 25 yr ago that >80% of the LPS remaining in the blood after injection was found in the plasma (4) . This observation, by Braude and his co-workers, was later confirmed by Herring et al. (5) although the properties of the LPS remaining in the plasma were not studied. Subsequently, Skarnes and Chedid (6) examined the immunologic properties of LPS remaining in the plasma of mice after intravenous injection. They demonstrated that a change in the immunodiffusion patterns of LPS was detected for the LPS remaining in the plasma and postulated that the LPS was converted by a degradative process from a large, slow diffusing molecule to a much smaller, rapidly diffusing form. A striking finding reported by Skarnes and Chedid was the persistence in the plasma of an LPS molecule which was still toxic for adrenalectomized mice. The molecular basis for both the altered immunodiffusion patterns as well as the residual toxicity as yet remains unexplained.
Most recently, using 125I-LPS (7) as a tracer molecule, we have described a reaction of LPS in plasma or serum which results in a marked reduction in the buoyant I Abbreviations used in this paper: DIPE, diisopropyl ether; DLHS, delipidated human serum; DLRP, delipidated rabbit plasma; HDL, high density lipoprotein; LDL, low density lipoprotein; LPS, lipopolysaccharide. density of the parent LPS to a value of <1.2 g/cm3 (8) . We showed that the reduction in LPS buoyant density did not occur as a result of enzymatic degradation of the glycolipid backbone of the LPS and that the reduction in buoyant density of LPS resulted in the abrogation of a number of the immediate biologic responses to LPS; namely, the pyrogenic response, the rapid neutropenia, and the anticomplementary activity.
Although the reduction in buoyant density accompanied a loss of these activities of the LPS, the mechanism associated with the physical change of the LPS remains unknown. We have therefore undertaken further experiments designed to gain understanding of the mechanism of the density reduction of LPS. The studies reported here, performed with LPS prepared from Escherichia coli 011l:B4 and from Salmonella minnesota R595, will provide evidence to support a critical role for plasma high density lipoprotein (HDL) in the conversion of the parent LPS to a form with a buoyant density of < 1.2 g/cm3. A preliminary report of these findings has been presented in abstract form (9) .
METHODS

Rabbits
Male New Zealand white rabbits ( The methods for preparation of the LPS have been described in detail (10, 11) . Radioiodination of 011l:B4 or R595 LPS was accomplished as described by Ulevitch (7) . The radioiodinated LPS has been shown to have the following properties: (a) the radioactivity is covalently bound and does not dissociate after treatment with either 10% sodium dodecyl sulfate, 8 M urea, or 5 M guanidine HCI; (b) the biophysical and immunologic properties of the radioiodinated LPS are identical with those of the parent LPS; and (c) the endotoxic properties are equivalent to those of the parent LPS. Radioiodinated LPS was stored at -20°C in the presence of 0.01% sodium azide.
Serum and plasma
Human venous blood was collected from the antecubital fossae of normal donors, allowed to clot in a glass tube for 60 min, 37°C, and the serum separated by centrifugation at 3,000 g for 30 min, 4°C. The serum was aliquoted, and stored at -70°C, thawed at 37°C and used immediately. Whole blood was also collected from the medial ear artery of rabbits, allowed to clot at 370C in a glass tube and processed as above. Platelet-free plasma was prepared from rabbit blood (anticoagulated with 5 mM EDTA) and delipidated as described below.
Delipidation of serum or plasma was accomplished by extraction with n-butanol/diisopropyl ether (DIPE) (40:60, vol/vol) essentially as described by Cham and Knowles (12) . Serum or plasma was extracted at 250C twice with 2 vol of butanol/DIPE for 60 min and once with 2 vol of DIPE for 2 min. To reduce the residual butanol after delipidation, samples, in a container covered with surgical gauze, were placed in a chemical hood overnight. A final concentration of 0.01% sodium azide was added to these solutions as an antibacterial agent.
Lipoproteins
Lipoproteins were prepared from normal human serum as previously described (13, 14) . Human lipoproteins were prepared from pooled human serum (usually four to six donors) so that the 1-wk preparation was initiated within 1 d of the serum collection. For the experiments described here the very low density lipoprotein (VLDL) was utilized within 3 d of isolation whereas the low density lipoproteins (LDL) and HDL were always used within 1 wk after isolation. Briefly, VLDL was isolated by centrifugation at plasma density (d = 1.006 g/cm3) for 24 h at 50,000 rpm in a Beckman-Spinco L2-65B ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) using a 6OTi rotor. LDL was isolated as the d = 1.02-1.063-g/cm3 fraction after adjustment of density by addition ofsolid NaBr (15) .
Analytical techniques
Ultracentrifugation. CsCl isopycnic density gradient ultracentrifugation was performed and data analyzed as previously described (10) . Although the CsCl ultracentrifugation experiments were usually run for 60 h, 48-and 72-h runs were initially performed to establish that equilibrium had been reached by 48 h. In no case were differences noted in the distribution of '25I-LPS in the 48-, 60-, or 72-h runs. Sucrose gradient ultracentrifugation was performed with 5-20% sucrose gradients at 45,000 rpm for 3 h in a SW 50.1 rotor. The distribution of radioactivity in CsCl gradients is plotted as total radioactivity per fraction vs. normalized gradient position where the normalized gradient position is calculated from the ratio of the (individual fraction number) /(total number of fractions).
LPS-induced physiologic changes in rabbits. The methods employed to determine the effect of LPS of tmCr platelet levels and core temperature are described in detail in a previous publication (16 Molecular exclusion chromatography. Sepharose 2B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) chromatography was performed at room temperature. The sample (0.5 ml) was added to a 10-ml column of Sepharose 2B in 0.15 M NaCl (0.9 x 24 cm, prepared in a 10-ml plastic pipette) and 0.2-ml fractions were collected. The column was calibrated with blue dextran, 1251-immunoglobulin (Ig)G and cytochrome c for determination of Vo, mol wt = 160,000 marker and Vt, respectively.
Experimental protocols
The experiments described in this paper were performed with normal or delipidated plasma or serum from human and rabbit sources. The source of the plasma or serum used for individual experiments will be specified in the text. The effect of serum or plasma on the bouyant density of either 0011l:B4 or R595 LPS was examined as follows. The final volume ofeach reaction to be studied was 0.4 ml and consisted of the following reagents added together sequentially: (a) 0.3 ml normal or delipidated serum or plasma; (b) 0.09 ml saline or purified lipoprotein; (c) 0.01 ml 125I-LPS.
These solutions were mixed and maintained at 37°C for varying lengths oftime. The reaction between LPS and serum or plasma was terminated by the addition of 5.0 ml of cold CsCl as previously reported (8) . For experiments with 0111:B4 LPS each reaction mixture contained 20 ,ug of LPS.
Experiments with R595 LPS utilized 10lg of LPS and the reaction mixture always contained 20 mM EDTA, pH 7.5. We have previously shown that the addition of EDTA to normal serum markedly increased the amount of R595 LPS which is converted to a form with d < 1.2 g/cm3 (8) .
Preparation of serum altered (d < 1.2 glcm3) LPS. LPS with ad < 1.2 g/cm3 was isolated from solutions of delipidated rabbit plasma (DLRP) and HDL by the preparative methods as previously described (8) . The LPS with a d < 1.2 g/cm3 was dialyzed exhaustively against 0.15 M saline at 4°C. The concentration of the LPS at d < 1.2 g/cm3 was calculated from the specific activity of the starting 125I-LPS. In control experiments we established that CsCl ultracentrifugation of LPS/saline solutions did not alter the biologic activity of the parent 011l:B4 or R595 LPS (7, 8 Role of serum lipid in the decrease in buoyant density ofLPS. To investigate the role of lipids in the serum-induced density reduction we prepared delipidated human serum (DLHS) by extraction of normal human serum with butanol/DIPE (12) . The effect of DLHS on the buoyant density of Oll:B4 and R595 LPS was then examined in the following experiment; 125I-LPS was added to DLHS or saline, maintained at 37°C for 60 min, and then equilibrium density gradient ultracentrifugation was performed. The analysis of the distribution of radioactivity is shown in Fig. 2 . As shown, the addition of R595 LPS to DLHS (containing 20 mM EDTA) produced a decrease in density from 1.38 (Fig. 2a ) to 1.34 g/cm3 (Fig. 2b) . The addition of 0111:B4 LPS to DLHS (Fig. 2d) Reconstitution of delipidated serum with purified lipoproteins. The previous experiment demonstrated that the removal of lipid from serum or plasma prevented the reduction in buoyant density of LPS to < 1.2 g/cm3. We next sought to determine if the activity of delipidated serum could be restored with purified serum lipoproteins because we could not exclude the possibility that the delipidation procedure denatured a component of serum required for the density reduction to <1.2 g/cm3.
125I-LPS was added to DLHS containing increasing amounts ofVLDL, LDL, or HDL so that the lipoprotein concentrations were reconstituted to between 20 and 200% of normal human serum levels. The reaction mixtures were maintained at 37°C for 60 min and, after the addition of cold CsCl, centrifuged to equilibrium. The distribution of the radioactivity in these gradients was determined and the percentage of LPS banding at a d < 1.2 g/cm3 was calculated.
The effect of adding increasing concentrations of purified lipoproteins to DLHS on the buoyant density of R595 as well as 0111:B4 LPS are summarized in Fig. 3 . Results obtained with 0111:B4 LPS shown in Fig. 3a) amounts of 0lll:B4 and R595 LPS found to band at d <1.2 g/m3 are shown in Table I . The results obtained when 0111:B4 LPS was mixed with purified lipoproteins indicate that VLDL or HDL interacted poorly with 0111:B4 LPS in the absence of delipidated serum so that no more than 12% of the 0111:B4 LPS banded at a d < 1.2 g/cm3. In contrast, LDL did interact more effectively so that 20% of the LPS in the gradient was found at ad < 1.2 g/cm3. These results suggest then that components of delipidated serum participate in the density reduction of 011l:B4 LPS, although 011l:B4 LPS can interact with LDL in the absence of serum.
The effect of addition of purified lipoproteins in the absence of serum, on the density of R595 LPS, was somewhat greater. Both VLDL and HDL caused 25% ofthe R595 LPS to shift to a d < 1.2 g/cm3 whereas LDL altered 40% of the LPS in this way.
The amount of either 0111: B4 or R595 LPS shifted to ad < 1.2 g/cm3 by lipoproteins in the absence of serum, was identical to that shown in Table I regardless of whether the lipoprotein concentration was 20 or 200% of normal serum levels. The LPS which was not converted by the purified lipoproteins to a d < 1.2 g/cm3 remained at the same density and displayed an identical band width as the parent LPS (data not shown). Studies are in progress to elucidate the mechanism of this direct effect of lipoproteins on the density of LPS. Fig. 4 demonstrate that the serum-altered forms of both LPS preparations eluted slightly ahead of IgG and after the parent LPS. Greater than 80% of the radioactivity applied to the Sepharose 2B column was recovered in the peaks shown in Fig. 4 . The parent R595 LPS elutes largely in the void volume (V'I) and the elution position of the parent Oll:B4 LPS is shown in Fig. 4 . Therefore, these findings suggest that size reduction of the parent LPS has occurred before or at the same time as the interaction with HDL. In experiments not shown here we have determined that the addition of HDL to the parent 011l:B4 LPS in the absence of other serum components, did not produce a disaggregation ofthe LPS.2 Thus, it seemed possible that a component not extracted by butanol/DIPE might produce the disaggregation.
To determine if delipidated serum had the capacity to alter the particle size ofthe parent LPS we performed the following experiment with R595 LPS. Peak tubes from CsCl gradients ofthe parent R595 LPS (Fig. 2a) or R595 LPS plus delipidated serum (Fig. 2b) dose of LPS which produced a 1°-1.5°C increase in core temperature during a 300-min period (8) . The results of this experiment are shown in Fig. 6 , where we have plotted the change from base-line temperature vs. time after LPS injection. These data, the mean value for three animals in each group, show that neither DLRP nor HDL alone inhibit the pyrogenic activity of 0111:B4 LPS, but that when DLRP and HDL are combined the LPS (d < 1.2 g/cm3) isolated from this mixture is devoid of pyrogenic activity. These data demonstrate that reconstitution of delipidated serum or plasma with HDL restores the ability of this mixture to inactivate LPS. Identical findings have been obtained for R595 LPS. In experiments to be reported elsewhere we have determined that the LPS isolated from mixtures of LPS + DLRP or LPS + HDL retained the ability to induce a pyrogenic response and neutropenia (see below) which was indistinguishable from that produced by the parent LPS. Furthermore, separate injections of DLRP or HDL alone did not produce a pyrogenic response or neutropenia (see below).
LPS injection into rabbits results in a rapid and profound neutropenia (8, 16 ) and this phenomenon can be utilized as a sensitive assay for the presence of LPS. We next examined this activity using either serumaltered LPS isolated from mixtures of 0111:B4 +DLRP + HDL or 0111:B4 LPS mixed with DLRP. The serumaltered 0111:B4 LPS isolated from DLRP + HDL mixtures was unable to induce an immediate neutropenia after the injection of up to 5 gg of this material.
In contrast, the injection of 0111:B4 LPS incubated with DLRP resulted in an immediate neutropenia. In these experiments the neutrophil levels remained at preinjection levels for 60 min after the injection of 5 gg of serum-altered 0111:B4 LPS (d < 1.2 g/cm3), whereas the injection of as little of 50 ng of 0111:B4 LPS in 1 ml of DLRP reduced the circulating neutrophil levels to <10% of the preinjection value. Thus, DLRP was unable to inhibit this activity of LPS. One sensitive measure of the anticomplementary activity of R595 LPS is the rapid, transient thrombocytopenia following intravenous injection into rabbits (16, 17) . This effect is dependent upon intravascular complement activation and as little as 50 ug of R595 LPS produces a 30-50% decrease in circulating platelets 5 min after injection (16 density of LPS to <1.2 g/Cm3. The present studies also
showed that nonlipid components of plasma (or serum) modify LPS, possibly by disaggregation and thus facilitating the interaction with HDL. The delipidated plasma (or serum) failed to inhibit several different LPS-dependent biologic responses, namely, the pyrogenic response and the immediate neutropenia in rabbits. Importantly, the addition of purified HDL to delipidated plasma (or serum) restored both the ability to reduce the buoyant density of LPS to <1.2 g/cm3
as well as the capacity to abrogate the activities of LPS responsible for the pyrogenic response, immediate thrombocytopenia and anticomplementary activity. Two different LPS preparations have been utilized for these experiments; namely that isolated from a smooth strain of E. coli, 0111:B4 and from a rough mutant of S. minnesota, R595. The former LPS is highly water soluble, has a mol wt of _1 x 106, consists of _50% by weight of lipid A, and has been shown to be an activator of the alternative complement pathway (18) . In contrast R595 LPS is a large macromolecular aggregate with a sedimentation coefficient of >50S, consists of >90% by weight of lipid A and has been shown to be an activator of the classical complement pathway (18) . Despite these differences both LPS preparations have been previously shown to produce similar pathophysiologic changes in rabbits (16) . Furthermore as shown in the present paper these LPS preparations interact with serum components, apparently by the same mechanism, so that the buoyant density of the parent LPS is reduced to <1.2 gcm3.
The evidence to support the participation of HDL is derived from experiments in which we compared the ability of purified lipoproteins to reconstitute delipidated serum (or plasma). These experiments clearly showed that HDL, at physiologic concentrations, restored the ability of delipidated serum to reduce the density of both 0111:B4 as well as R595 LPS to a value of <1.2 g/Cm3. In contrast, VLDL and LDL, added to twice normal serum levels were ineffective although LDL partially restored the activity of delipidated serum when R595 was examined.
Our experimental findings also suggest that LPS undergoes modification before interaction with HDL. In the case of 0111:B4 LPS the addition of HDL to the parent LPS did not result in a significant amount of LPS being altered to a d < 1.2 g/cm3 (Table I) (Fig. 5 ). This experiment showed that delipidated serum produced a marked reduction in the sedimentation rate of the parent LPS. The possibility that lipid-free serum cQmponents produced a conformational change in the LPS, resulting in a markedly decreased sedimentation rate cannot be excluded. However, the modifications of LPS, produced after exposure to delipidated plasma (or serum), may reflect changes which occur in normal plasma and are of critical importance in the conversion of the parent LPS to a form with d < 1.2 g/cm3. This possibility is currently under investigation.
Finally, the molecular weight of the serum-altered form of 0111:B4 or R595 LPS (d < 1.2 g/cm3) was markedly less than that of the parent LPS. These data also suggest that a disaggregation of the LPS occurs before or in concert with the reduction in d < 1.2 g/cm3.
In an earlier publication we suggested that the interaction of LPS with plasma (or serum) resulting in a reduction of the buoyant density of LPS to <1.2 g/cm3 could be explained by a two-step mechanism. The experimental results reported in the present paper are consistent with this scheme shown below:
Step I: (LPS)native + plasma factor(s) = (LPS)disaggregated
Step II: (LPS)disaggregated + HDL + (LPS)d< 1.2gICm3
The loss of endotoxic activity requires the interaction of the LPS product of step I with HDL to produce the LPS with ad < 1.2 g/cm3. It is likely that the conversion of LPS to a form with a d < 1.2 g/cm3 results from complex formation between the disaggregated LPS and HDL so that the LPS acquires the density characteristics of the HDL. This possibility is currently under investigation.
We have previously shown that conversion of LPS to a form with d < 1.2 g/cm3 results in the abrogation of several biologic activities of LPS, most notably those expressed by the immediate host responses to LPS. However, it was demonstrated that the serum-altered LPS (d < 1.2 g/cm3) was still toxic when assayed in a mouse lethality assay (8) . These findings suggested that the serum-altered LPS may still retain the ability to interact with host defense systems and produce mediators responsible for LPS-induced injury.
To further explore the toxic properties of the serumaltered LPS (d < 1.2 g/cm3) we have examined the ability of this LPS to produce shock and disseminated intravascular coagulation in rabbits. These studies, to be reported elsewhere, indicated that the capacity of the serum-altered form (d < 1.2 g/cm3) to induce shock and disseminated intravascular coagulation in rabbits is not inhibited. 3 The mechanism of this toxicity as yet remains unexplained. However, we have shown that in contrast to the parent LPS, the serum-altered form of R595 LPS was specifically concentrated in the adrenals reaching concentrations of LPS per gram tissue up to fivefold greater than that appearing in any other organs including the liver, lungs, and spleen. The mechanism and biologic effect of the adrenal uptake is of particular interest because this tissue contains cells with high affinity receptors for lipoproteins (19) (20) (21) . Our finding ofaccumulation ofthe serum-altered LPS in the adrenal suggests that the LPS may have acquired apolipoproteins responsible for interaction at these sites.
Experiments are currently in progress to examine the following: (a) An evaluation ofthe importance of step I ofthe proposed mechanism for conversion ofthe parent LPS to the low-density form. (b) The contribution which lipoprotein lipids and apolipoproteins make to the conversion of LPS to a form with d < 1.2 g/cm3.
